These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 1894199)
1. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model. Krupinski K; Breddin HK Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic action of recombinant hirudin in a venous thrombosis model. Raake W; Klauser RJ; Elling H; Zeiller P Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293 [TBL] [Abstract][Full Text] [Related]
3. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model. Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787 [TBL] [Abstract][Full Text] [Related]
4. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304 [TBL] [Abstract][Full Text] [Related]
5. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin. Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis model. Doutremepuich C; Lalanne MC; Doutremepuich F; Walenga J; Fareed J; Breddin HK Haemostasis; 1991; 21 Suppl 1():99-106. PubMed ID: 1894201 [TBL] [Abstract][Full Text] [Related]
7. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998 [TBL] [Abstract][Full Text] [Related]
8. Effects of combinations of a prostacyclin analogue (Cicaprost) with different antithrombotic agents in a rat microcirculatory thrombosis model. Giedrojc J; Breddin HK Int J Microcirc Clin Exp; 1992 Aug; 11(3):277-86. PubMed ID: 1324230 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin. Doutremepuich C; Deharo E; Guyot M; Lalanne MC; Walenga J; Fareed J Thromb Res; 1989 Jun; 54(5):435-45. PubMed ID: 2772867 [TBL] [Abstract][Full Text] [Related]
10. Reocclusion after thrombolysis: a problem solved by hirudin? Rübsamen K; Eschenfelder V Blood Coagul Fibrinolysis; 1991 Feb; 2(1):97-100. PubMed ID: 1773004 [TBL] [Abstract][Full Text] [Related]
11. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group. Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044 [TBL] [Abstract][Full Text] [Related]
13. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274 [TBL] [Abstract][Full Text] [Related]
14. A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons. Kotzé HF; Lamprecht S; Badenhorst PN Blood; 1995 Jun; 85(11):3158-63. PubMed ID: 7756648 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model. Giedrojc J; Breddin HK Thromb Res; 1991 Jul; 63(1):99-110. PubMed ID: 1948825 [TBL] [Abstract][Full Text] [Related]
16. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits. Agnelli G; Pascucci C; Cosmi B; Nenci GG Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121 [TBL] [Abstract][Full Text] [Related]
17. The effects of recombinant desulphatohirudin on arterial thrombosis in rats. Talbot MD; Ambler J; Butler KD; Lees CM; Mitchell KA; Peters RF; Tweed MF; Wallis RB Haemostasis; 1991; 21 Suppl 1():73-9. PubMed ID: 1654294 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins. Zhang B; Wieslander JB Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of recombinant hirudin in different animal models. Just M; Tripier D; Seiffge D Haemostasis; 1991; 21 Suppl 1():80-7. PubMed ID: 1716605 [TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits. Rübsamen K; Eschenfelder V Haemostasis; 1991; 21 Suppl 1():93-8. PubMed ID: 1894200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]